Literature DB >> 16685849

A novel 3D partitioned active shape model for segmentation of brain MR images.

Zheen Zhao1, Stephen R Aylward, Earn Khwang Teoh.   

Abstract

A 3D Partitioned Active Shape Model (PASM) is proposed in this paper to address the problems of the 3D Active Shape Models (ASM). When training sets are small. It is usually the case in 3D segmentation, 3D ASMs tend to be restrictive. This is because the allowable region spanned by relatively few eigenvectors cannot capture the full range of shape variability. The 3D PASM overcomes this limitation by using a partitioned representation of the ASM. Given a Point Distribution Model (PDM), the mean mesh is partitioned into a group of small tiles. In order to constrain deformation of tiles, the statistical priors of tiles are estimated by applying Principal Component Analysis to each tile. To avoid the inconsistency of shapes between tiles, training samples are projected as curves in one hyperspace instead of point clouds in several hyperspaces. The deformed points are then fitted into the allowable region of the model by using a curve alignment scheme. The experiments on 3D human brain MRIs show that when the numbers of the training samples are limited, the 3D PASMs significantly improve the segmentation results as compared to 3D ASMs and 3D Hierarchical ASMs.

Entities:  

Mesh:

Year:  2005        PMID: 16685849     DOI: 10.1007/11566465_28

Source DB:  PubMed          Journal:  Med Image Comput Comput Assist Interv


  2 in total

1.  Localized Principal Component Analysis based Curve Evolution: A Divide and Conquer Approach.

Authors:  Vikram Appia; Balaji Ganapathy; Anthony Yezzi; Tracy Faber
Journal:  IEEE Int Conf Comput Adv Bio Med Sci       Date:  2011-11-06

2.  Analysis of the three-dimensional anatomical variance of the distal radius using 3D shape models.

Authors:  Sebastian F Baumbach; Jakob Binder; Alexander Synek; Fabian G Mück; Yan Chevalier; Ekkehard Euler; Georg Langs; Lukas Fischer
Journal:  BMC Med Imaging       Date:  2017-03-09       Impact factor: 1.930

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.